Candida Research Today is a free monthly online journal that collates and summarizes the latest research about Candida, including details on thrush infections, yeast, diet, treatment, symptoms.

Volume 2 (2005), Issue 5 (May)

1. Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes.
   J Antimicrob Chemother, 55(5): 785-7. [Abstract] [Full-text]
2. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.
   J Antimicrob Chemother, 55(5): 645-54. [Abstract] [Full-text]
3. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
   J Antimicrob Chemother, 55(5): 655-62. [Abstract] [Full-text]
4. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
   J Antimicrob Chemother, 55(5): 663-73. [Abstract] [Full-text]
5. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
   J Antimicrob Chemother, 55(5): 692-8. [Abstract] [Full-text]
6. The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence.
   Microbiology, 151: 1645-55. [Abstract] [Full-text]
7. Torulopsis glabrata fungemia from infected transjugular intrahepatic portosystemic shunt stent.
   J Vasc Interv Radiol, 16(5): 751-2. [Abstract] [Full-text]
8. Use of a commercial reagent leads to reduced germ tube production by Candida dubliniensis.
   J Clin Microbiol, 43(5): 2465-6. [Abstract] [Full-text]
9. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections.
   J Clin Microbiol, 43(5): 2181-7. [Abstract] [Full-text]
10. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
    J Clin Microbiol, 43(5): 2155-62. [Abstract] [Full-text]
11. Carbohydrate assimilation profiles of Brazilian Candida dubliniensis isolates based on ID 32C system.
    Rev Inst Med Trop Sao Paulo, 47(2): 109-11. [Abstract] [Full-text]
12. Relationship of DFG16 to the Rim101p pH response pathway in Saccharomyces cerevisiae and Candida albicans.
    Eukaryot Cell, 4(5): 890-9. [Abstract] [Full-text]
13. Isolation of cholesterol-dependent Candida glabrata from clinical specimens.
    Diagn Microbiol Infect Dis, 52(1): 35-7. [Abstract] [Full-text]
14. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI.
    Science, 308(5723): 866-70. [Abstract] [Full-text]
15. Increased virulence and competitive advantage of a/alpha over a/a or alpha/alpha offspring conserves the mating system of Candida albicans.
    Genetics, 169(4): 1883-90. [Abstract] [Full-text]
16. Microbiology of middle ear effusions from 292 patients undergoing tympanostomy tube placement for middle ear disease.
    Int J Pediatr Otorhinolaryngol, 69(6): 799-804. [Abstract] [Full-text]
17. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection.
    J Med Microbiol, 54: 583-93. [Abstract] [Full-text]
18. In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative.
    J Med Microbiol, 54: 549-52. [Abstract] [Full-text]
19. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
    Arch Dermatol, 141(5): 589-94. [Abstract] [Full-text]
20. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane.
    Biochem J, 388: 689-95. [Abstract] [Full-text]
21. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.
    Infect Immun, 73(6): 3714-24. [Abstract] [Full-text]
22. Antifungal effect and possible mode of activity of a compound from the marine sponge Dysidea herbacea.
    J Infect, 50(5): 453-60. [Abstract] [Full-text]
23. The effect of radiation therapy on fungal growth: results of in vitro and in vivo studies.
    J Infect, 50(5): 450-2. [Abstract] [Full-text]
24. Caspofungin in combination with amphotericin B against Candida glabrata.
    Antimicrob Agents Chemother, 49(6): 2546-9. [Abstract] [Full-text]
25. Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells.
    Antimicrob Agents Chemother, 49(6): 2336-42. [Abstract] [Full-text]
26. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation.
    Antimicrob Agents Chemother, 49(6): 2329-35. [Abstract] [Full-text]
27. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
    Antimicrob Agents Chemother, 49(6): 2226-36. [Abstract] [Full-text]
28. Effect of dairy products on the lifetime of Provox2 voice prostheses in vitro and in vivo.
    Head Neck, 27(6): 471-7. [Abstract] [Full-text]
29. Effect of different levels of NADH availability on metabolic fluxes of Escherichia coli chemostat cultures in defined medium.
    J Biotechnol, 117(4): 395-405. [Abstract] [Full-text]
30. Candida riodocensis and Candida cellae, two new yeast species from the Starmerella clade associated with solitary bees in the Atlantic rain forest of Brazil.
    FEMS Yeast Res, 5(9): 875-9. [Abstract] [Full-text]
31. Potential of plant oils as inhibitors of Candida albicans growth.
    FEMS Yeast Res, 5(9): 867-73. [Abstract] [Full-text]

© 2004-2008 Candida Research Today. All Rights Reserved.